Cross-linked glycopeptide-cephalosporin antibiotics

Details Cross-linked glycopeptide-cephalosporin antibiotics Cross-linked glycopeptide-cephalosporin antibiotics

2006-02-07

2006-02-07

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

06995138

ABSTRACT:
This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.

REFERENCES:
patent: 4220761 (1980-09-01), Takaya et al.
patent: 4341775 (1982-07-01), Takaya et al.
patent: 4366153 (1982-12-01), Takaya et al.
patent: 4487767 (1984-12-01), Takaya et al.
patent: 4921851 (1990-05-01), Kishimoto et al.
patent: 4943567 (1990-07-01), Nishizawa et al.
patent: 5693791 (1997-12-01), Truett
patent: 6437119 (2002-08-01), Truett
patent: 6878686 (2005-04-01), Marquess et al.
patent: 2003/0130173 (2003-07-01), Fatheree et al.
patent: 2004/0266666 (2004-12-01), Fatheree et al.
patent: 2005/0026818 (2005-02-01), Fatheree et al.
patent: 2 033 377 (1980-05-01), None
patent: 60-41682 (1985-03-01), None
patent: WO 99/42476 (1999-08-01), None
patent: WO 99/64049 (1999-12-01), None
patent: WO 00/39156 (2000-07-01), None
patent: WO 03/031449 (2003-04-01), None
U.S. Appl. No. 09/457,926, filed Dec. 8, 1999, Christensen et al.
Boeckh et al., “Pharmacokinetics and Serum Bactericidal Activity of Vancomycin Alone and in Combination with Ceftazidime in Healthy Volunteers”, Antibacterial Agents and Chemotherapy, vol. 32, No. 1, pp 92-95 (1988).
Hammes, W. P., “Biosynthesis of Peptidoglycan inGalfkya homari,The Mode of Action of Penicillin G and Mecillinam”, Eur. J. Biochem., vol. 70, pp 107-113 (1976).
Kim et al., “Synthesis and Antibacterial Activity of Cephalosporins Having Hydroxamic Acid at C-7 Postion”, Biorganic & Med. Chem. Letters, vol. 6, No. 17, pp 2077-2080 (1996).
Lattrell et al., “Synthesis and Structure-Activity Relationships in the Cefpirome Series”, Journal of Antibiotics, vol. XLI, No. 10, pp 1374-1394 (1988).
Pavlov et al., A New Type of Chemical Modification of Glycopeptides Antibiotics: Aminomethylated Derivatives of Eromomycin and Their Antibacterial Activity, The Journal of Antibiotics, vol. 50, No. 6, pp 509-513 (1997).
Pavlov et al., “Chemical Modification of Glycopeptide Antibiotics [VC1]”, Russian Journal of Bioorganiz Chemistry, vol. 24, No. 9, pp 570-587 (1998).
Rao et al., “Tight Binding of a Dimeric Derivative of Vancomycin with Dimeric L-Lys-D-Ala-D-Ala”, J. Am. Chem. Soc. vol. 119, pp 10286-10290 (1997).
Renoud-Grappin et al., “Imidazo[1,5-b]pyridazine-d4T conjugates:synthesis and anti-human immunodeficiency virus evaluation”, Antiviral Chemistry & Chemotherapy, vol. 9, pp 205-223.
Staroske et al., “Synthesis of Covalent Head-to-Tail Dimers of Vancomycin”, Tetrahedron Letters, vol. 39, pp 4917-4920 (1998).
Sundram et al., “General and Efficient Method for the Solution- and Solid-Phase Synthesis of Vancomycin Carboxamide Derivatives”, J. Org. Chem., vol. 60, pp 1102-1103 (1995).
Sundram et al., “Novel Vancomycin Dimers with Activity against Vancoymcin-Resistant Enterococci”, J. Am.Chem. Soc., vol. 118, pp 13107-13108 (1996).

Affiliated with

Also associated with

Rating

Cross-linked glycopeptide-cephalosporin antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cross-linked glycopeptide-cephalosporin antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-linked glycopeptide-cephalosporin antibiotics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3675589